EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Photobiomodulation therapy in the prevention of chemotherapy-induced alopecia in breast cancer patients: a randomized controlled trial

Marithé Claes, Jolien Robijns, Laura Lambrichts, Sofie Van Duffel, Philippe Bulens, Jeroen Mebis

Lasers in Medical Science · 2025

DOI: 10.1007/s10103-025-04577-7 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Lasers in Medical Science, 2025. Verfasst von Marithé Claes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hasselt University, Hasselt, Belgium. marithe.claes@uhasselt.be. Hauptthemen laut MEDLINE: Alopecia, Breast Neoplasms, Low-Level Light Therapy, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Limburg Clinical Research Center, Limburgs Kankerfonds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Chemotherapy-induced alopecia (CIA) is a prominent side effect of chemotherapy, negatively impacting the patient's body image and self-confidence. Scalp cooling (SC) has emerged as a preventive option for CIA, but the success rate and adherence vary. Research shows that photobiomodulation (PBM) can improve hair growth by stimulating cell proliferation and repair processes. This trial aims to evaluate the effectiveness of PBM combined with SC in preventing CIA. METHODS: A randomized, controlled trial with 29 breast cancer patients undergoing taxane-based chemotherapy was performed at the Jessa Hospital (Belgium). Patients were randomized into the control (n = 16) or the intervention group (n = 13). Blinded researchers evaluated scalp coverage and hair thickness, while questionnaires were administered to assess scalp coverage, satisfaction, and health-related quality of life (HRQL). The trial was registered at clinicaltrials.gov (NCT05177289, 4th of January 2022). RESULTS: The scalp coverage and hair thickness did not differ significantly between the two groups. Patients in the PBM group scored higher on global health (P = 0.043), physical functioning (P = 0.039), role functioning (P = 0.049), and social functioning (P = 0.038). Patients receiving a paclitaxel-based chemotherapy showed less hair loss compared to patients undergoing a docetaxel-based regimen (Ps < 0.001). No differences in SC adherence could be observed between the two groups. CONCLUSIONS: The addition of PBM to SC did not increase its efficacy in preventing hair loss during chemotherapy. Patients in the PBM group did score their HRQL higher compared to the control group. Further research is required to establish the use of PBM in CIA prevention and to corroborate these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlopeciaBreast NeoplasmsLow-Level Light TherapyAntineoplastic AgentsHumansFemaleMiddle AgedAdultQuality of LifeTaxoidsAgedScalp

Stichwörter der Autor:innen

AlopeciaBreast cancerChemotherapyPhotobiomodulationQuality of lifeScalp cooling

Substanzen

TaxoidsAntineoplastic Agents

Autor:innen und Institutionen

  • Hasselt University, Hasselt, Belgium. marithe.claes@uhasselt.be.
  • Hasselt University, Hasselt, Belgium.
  • Jessa Hospital, Hasselt, Belgium.

Förderung

  • Limburg Clinical Research Center
  • Limburgs Kankerfonds

Zitieren

APA

Claes, M., Robijns, J., Lambrichts, L., Van Duffel, S., Bulens, P., & Mebis, J. (2025). Photobiomodulation therapy in the prevention of chemotherapy-induced alopecia in breast cancer patients: a randomized controlled trial. Lasers in Medical Science. https://doi.org/10.1007/s10103-025-04577-7

Vancouver

Claes M, Robijns J, Lambrichts L, Van Duffel S, Bulens P, Mebis J. Photobiomodulation therapy in the prevention of chemotherapy-induced alopecia in breast cancer patients: a randomized controlled trial. Lasers in Medical Science. 2025. doi:10.1007/s10103-025-04577-7

BibTeX
@article{Claes2025,
  author = {Claes, Marithé and Robijns, Jolien and Lambrichts, Laura and Van Duffel, Sofie and Bulens, Philippe and Mebis, Jeroen},
  title = {Photobiomodulation therapy in the prevention of chemotherapy-induced alopecia in breast cancer patients: a randomized controlled trial},
  journal = {Lasers in Medical Science},
  year = {2025},
  doi = {10.1007/s10103-025-04577-7}
}
Kostenlos starten →